Summary:
A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus
Qualified Participants Must:
10 to 18 years old
HbA1c 6.5% to 11.0%
Qualified Participants May Receive:
Free lab tests, free examinations, and reimbursement for travel and time